Close Menu

Locus Biosciences is trying to combat so-called superbugs — bacteria that are resistant to many antibiotics — by engineering the bacteriophages that naturally infect them, NPR reports.

The firm, it says, is using CRISPR to develop a mix of three phages to target particular bacterial genes, that way the treatment only targets particular bacteria.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

According to NPR, an antibody-based test could identify people who were exposed to SARS-CoV-2 and either didn't develop symptoms or were misdiagnosed.

A sequencing analysis of New York City rats indicates they have adapted to the urban environment there, according to a recent preprint.

Ars Technica reports that a multicellular eukaryotic parasite has lost its mitochondria.

In Science this week: perspective piece says AI can accelerate drug discovery by using genomic and chemical data, and more.